» Articles » PMID: 17048303

Association of Graves' Disease and Graves' Ophthalmopathy with the Polymorphisms in Promoter and Exon 1 of Cytotoxic T Lymphocyte Associated Antigen-4 Gene

Overview
Date 2006 Oct 19
PMID 17048303
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the association of Graves' disease and Graves' ophthalmopathy with the C/T transition polymorphism at position -318 of promoter and the A/G transition polymorphism at position 49 of exon 1 within cytotoxic T lymphocyte associated antigen-4 (CTLA-4) gene.

Methods: Thirty-three patients with ophthalmopathy of Graves' disease, fifty-six Graves' patients without ophthalmopathy and sixty normal subjects as control were involved in the present case-control study. The polymorphisms were evaluated by polymerase chain reaction fragment length polymorphism (PCR-RFLP). Comparisons were made of gene frequencies and allele frequencies between the groups.

Results: The gene frequencies of CT and allele frequencies of T were much higher in Graves' patients with ophthalmopathy than that in the group without ophthalmopathy (P=0.020, P=0.019). The gene frequencies of GG and allele frequencies of G in patients with Graves' disease were significantly increased as compared with control group (P=0.008, P=0.007). The data suggest that smokers with Graves' disease seemed to be more predisposed to ophthalmopathy than non-smokers (P=0.018).

Conclusion: Our results suggest that an allele of T at position -318 of promoter is associated with genetic susceptibility to Graves' ophthalmopathy while an allele of G at position 49 of exon 1 is associated with genetic susceptibility to Graves' disease instead. Smoking is believed to be a major risk factor for ophthalmopathy.

Citing Articles

Immune checkpoints: new insights into the pathogenesis of thyroid eye disease.

Shu X, Shao Y, Chen Y, Zeng C, Huang X, Wei R Front Immunol. 2024; 15:1392956.

PMID: 38817600 PMC: 11137266. DOI: 10.3389/fimmu.2024.1392956.


The risk factors for Graves' ophthalmopathy.

Cao J, Su Y, Chen Z, Ma C, Xiong W Graefes Arch Clin Exp Ophthalmol. 2021; 260(4):1043-1054.

PMID: 34787691 DOI: 10.1007/s00417-021-05456-x.


Investigation of the Correlation between Graves' Ophthalmopathy and CTLA4 Gene Polymorphism.

Chen D, Chu Y, Wen Y, Lin W, Hour A, Wang W J Clin Med. 2019; 8(11).

PMID: 31684013 PMC: 6912222. DOI: 10.3390/jcm8111842.


Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.

Shih Y, Lu H, Hsiao C, Ho K, Chen P, Huang C Int J Med Sci. 2018; 15(4):395-402.

PMID: 29511375 PMC: 5835710. DOI: 10.7150/ijms.23097.


Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.

Ting W, Chien M, Lo F, Wang C, Huang C, Lin C PLoS One. 2016; 11(4):e0154394.

PMID: 27111218 PMC: 4844099. DOI: 10.1371/journal.pone.0154394.


References
1.
Prummel M, Van Pareren Y, Bakker O, Wiersinga W . Anti-heat shock protein (hsp)72 antibodies are present in patients with Graves' disease (GD) and in smoking control subjects. Clin Exp Immunol. 1997; 110(2):292-5. PMC: 2265493. DOI: 10.1111/j.1365-2249.1997.tb08330.x. View

2.
Braun J, Donner H, Siegmund T, Walfish P, Usadel K, Badenhoop K . CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens. 1998; 51(5):563-6. DOI: 10.1111/j.1399-0039.1998.tb02993.x. View

3.
Bartalena L, Marcocci C, Tanda M, Manetti L, DellUnto E, Bartolomei M . Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med. 1998; 129(8):632-5. DOI: 10.7326/0003-4819-129-8-199810150-00010. View

4.
Heward J, Allahabadia A, Carr-Smith J, Daykin J, Cockram C, Gordon C . No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol (Oxf). 1998; 49(3):331-4. DOI: 10.1046/j.1365-2265.1998.00542.x. View

5.
Vaidya B, Imrie H, Perros P, Dickinson J, McCarthy M, Kendall-Taylor P . Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet. 1999; 354(9180):743-4. DOI: 10.1016/S0140-6736(99)01465-8. View